|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2025―Jan―14 |
Sequential intranasal booster triggers class switching from intramuscularly primed IgG to mucosal IgA against SARS-CoV-2 |
Yifan Lin, Xuejiao Liao, Xuezhi Cao, Zhaoyong Zhang, Xiuye Wang, Xiaomeng He, et al. (+12) Huiping Liao, Bin Ju, Furong Qi, Hairong Xu, Zhenhua Ren, Yanqun Wang, Zhenxiang Hu, Jiaming Yang, Yang-Xin Fu, Jincun Zhao, Zheng Zhang, Hua Peng |
2 |
[GO] |
2025―Jan―07 |
CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infection |
Jian Zheng, Hima Dhakal, Enya Qing, Rejeena Shrestha, Anne E. Geller, Samantha M. Morrissey, et al. (+20) Divyasha Saxena, Xiaoling Hu, Hong Li, Haiyan Li, Kevin Wilhelmsen, Linder H. Wendt, Klaus Klumpp, Patrick S. Hume, William J. Janssen, Rachel Brody, Kenneth E. Palmer, Silvia M. Uriarte, Patrick P. Ten Eyck, David K. Meyerholz, Michael L. Merchant, Kenneth McLeish, Tom Gallagher, Jiapeng Huang, Jun Yan, Stanley Perlman |
3 |
[GO] |
2024―Dec―17 |
Long COVID is associated with lower percentages of mature, cytotoxic NK cell phenotypes |
Tasha Tsao, Amanda M. Buck, Lilian Grimbert, Brian H. LaFranchi, Belen Altamirano Poblano, Emily A. Fehrman, et al. (+9) Thomas Dalhuisen, Priscilla Y. Hsue, J. Daniel Kelly, Jeffrey N. Martin, Steven G. Deeks, Peter W. Hunt, Michael J. Peluso, Oscar A. Aguilar, Timothy J. Henrich |
4 |
[GO] |
2024―Nov―26 |
Structural characterization of human monoclonal antibodies targeting uncommon antigenic sites on spike glycoprotein of SARS-CoV |
Naveenchandra Suryadevara, Nurgun Kose, Sandhya Bangaru, Elad Binshtein, Jennifer Munt, David R. Martinez, et al. (+7) Alexandra Schäfer, Luke Myers, Trevor D. Scobey, Robert H. Carnahan, Andrew B. Ward, Ralph S. Baric, James E. Crowe Jr. |
5 |
[GO] |
2024―Oct―14 |
Neutralizing activity of anti-SARS-CoV-2 hyperimmune immunoglobulins and intravenous immunoglobulins against currently circulating SARS-CoV-2 variants |
Lorenza Bellusci, Hana Golding, Surender Khurana |
6 |
[GO] |
2024―Sep―12 |
A six-year study in a real-world population reveals an increased incidence of dyslipidemia during COVID-19 |
Valentina Trimarco, Raffaele Izzo, Stanislovas S. Jankauskas, Mario Fordellone, Giuseppe Signoriello, Maria Virginia Manzi, et al. (+11) Maria Lembo, Paola Gallo, Giovanni Esposito, Roberto Piccinocchi, Francesco Rozza, Carmine Morisco, Pasquale Mone, Gaetano Piccinocchi, Fahimeh Varzideh, Bruno Trimarco, Gaetano Santulli |
7 |
[GO] |
2024―Aug―14 |
The forgotten pandemic: how understanding cholera illuminated mechanisms of chloride channels in multiple diseases |
Qais Al-Awqati |
8 |
[GO] |
2024―Jul―11 |
Randomised controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccine |
Wen Shi Lee, Jennifer Audsley, Mai-Chi Trieu, Arnold Reynaldi, L. Carissa Aurelia, Palak H. Mehta, et al. (+15) Joanne Patterson, Helen E. Kent, Julie Nguyen, Thakshila Amarasena, Robyn Esterbauer, Ebene R. Haycroft, Pradhipa Ramanathan, Miles P. Davenport, Timothy E. Schlub, Joseph Sasadeusz, Adam K. Wheatley, Amy W. Chung, Jennifer A. Juno, Kevin J. Selva, Stephen J. Kent |
9 |
[GO] |
2024―Jun―30 |
The other pandemic: lessons from 40 years of HIV research |
Mary E. Klotman, Barton F. Haynes |
10 |
[GO] |
2024―Apr―30 |
Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality |
Jeremy P. Gygi, Cole Maguire, Ravi K. Patel, Pramod Shinde, Anna Konstorum, Casey P. Shannon, et al. (+37) Leqi Xu, Annmarie Hoch, Naresh Doni Jayavelu, Elias K. Haddad, Elaine F. Reed, Monica Kraft, Grace A. McComsey, Jordan P. Metcalf, Al Ozonoff, Denise Esserman, Charles B. Cairns, Nadine Rouphael, Steven E. Bosinger, Seunghee Kim-Schulze, Florian Krammer, Lindsey B. Rosen, Harm van Bakel, Michael Wilson, Walter L. Eckalbar, Holden T. Maecker, Charles R. Langelier, Hanno Steen, Matthew C. Altman, Ruth R. Montgomery, Ofer Levy, Esther Melamed, Bali Pulendran, Joann Diray-Arce, Kinga K. Smolen, Gabriela K. Fragiadakis, Patrice M. Becker, Rafick P. Sekaly, Lauren I.R. Ehrlich, Slim Fourati, Bjoern Peters, Steven H. Kleinstein, Leying Guan |
11 |
[GO] |
2024―Mar―31 |
Pandemics past, present, and future: progress and persistent risks |
Arturo Casadevall |
12 |
[GO] |
2024―Mar―14 |
Contralateral versus ipsilateral vaccine boosting for COVID-19: considering the broader scientific landscape |
Paul Goepfert |
13 |
[GO] |
2024―Mar―14 |
Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants |
Mengfei Chen, Andrew Pekosz, Jason S. Villano, Wenjuan Shen, Ruifeng Zhou, Heather Kulaga, et al. (+9) Zhexuan Li, Amy Smith, Asiana Gurung, Sarah E. Beck, Kenneth W. Witwer, Joseph L. Mankowski, Murugappan Ramanathan Jr., Nicholas R. Rowan, Andrew P. Lane |
14 |
[GO] |
2023―Nov―30 |
High-frequency home self-collection of capillary blood correlates IFI27 expression kinetics with SARS-CoV-2 viral clearance |
Fang Yun Lim, Soo-Young Kim, Karisma N. Kulkarni, Rachel L. Blazevic, Louise E. Kimball, Hannah G. Lea, et al. (+9) Amanda J. Haack, Maia S. Gower, Terry Stevens-Ayers, Lea M. Starita, Michael Boeckh, Ollivier Hyrien, Joshua T. Schiffer, Ashleigh B. Theberge, Alpana Waghmare |
15 |
[GO] |
2023―Nov―15 |
Cells that survive acute murine SARS-CoV-2 infection are detected nearly exclusively in the respiratory tract |
Ruangang Pan, David K. Meyerholz, Stanley Perlman |
16 |
[GO] |
2023―Oct―10 |
SARS-CoV2 mRNA-vaccination-induced immunological memory in human non-lymphoid and lymphoid tissues |
Vanessa Proß, Arne Sattler, Söeren Lukassen, Laura Tóth, Linda Marie Laura Thole, Janine Siegle, et al. (+29) Carolin Stahl, An He, Georg Damm, Daniel Seehofer, Christina Götz, Christian Bayerl, Pia Jäger, Alexander Macke, Stephan Eggeling, Bernadette Kirzinger, Thomas Mayr, Hermann Herbst, Katharina Beyer, Dominik Laue, Jan Krönke, Jan Braune, Friederike Rosseck, Beatrice Kittner, Frank Friedersdorff, Mandy Hubatsch, Sarah Weinberger, Nils Lachmann, Veit Maria Hofmann, Eva Schrezenmeier, Carolin Ludwig, Hubert Schrezenmeier, Katharina Jechow, Christian Conrad, Katja Kotsch |
17 |
[GO] |
2023―Sep―05 |
Vaccine effectiveness of BNT162b2 mRNA Covid-19 vaccine in children under 5 years |
Christoph Strumann, Otavio T. Ranzani, Jeanne Moor, Reinhard Berner, Nicole Toepfner, Cho-Ming Chao, Matthias B. Moor |
18 |
[GO] |
2023―Aug―15 |
Adverse outcomes in SARS-CoV-2 infected pregnant mice are gestational age-dependent and resolve with antiviral treatment |
Patrick S. Creisher, Jamie L. Perry, Weizhi Zhong, Jun Lei, Kathleen R. Mulka, W. Hurley Ryan, et al. (+7) Ruifeng Zhou, Elgin H. Akin, Anguo Liu, Wayne Mitzner, Irina Burd, Andrew Pekosz, Sabra L. Klein |
19 |
[GO] |
2023―Aug―10 |
Mast cell activation in lungs during SARS-CoV-2 infection associated with lung pathology and severe COVID-19 |
Janessa Yan Jun Tan, Danielle E. Anderson, Abhay P.S. Rathore, Aled O'Neill, Chinmay Kumar Mantri, Wilfried A.A. Saron, et al. (+13) Cheryl Q.E. Lee, Wern Cui Chu, Adrian E.Z. Kang, Randy Foo, Shirin Kalimuddin, Jenny G. Low, Lena Ho, Paul Tambyah, Thomas W. Burke, Christopher W. Woods, Kuan Rong Chan, Joern Karhausen, Ashley L. St. John |
20 |
[GO] |
2023―Jul―20 |
No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccines |
Natalie E. Stevens, Feargal J. Ryan, Nicole L. Messina, Stephen J. Blake, Todd S. Norton, Susie Germano, et al. (+8) Jane James, Georgina L. Eden, Yee C. Tee, Miriam A. Lynn, Rochelle Botten, Simone E. Barry, Nigel Curtis, David J. Lynn |
21 |
[GO] |
2023―May―23 |
Prevalence and functional profile of SARS-CoV-2 T cells in asymptomatic Kenyan adults |
Taraz Samandari, Joshua Ongalo, Kimberly McCarthy, Richard K. Biegon, Philister Madiega, Anne Mithika, et al. (+15) Joseph Orinda, Grace M. Mboya, Patrick Mwaura, Omu Anzala, Clayton Onyango, Fredrick O. Oluoch, Eric M. Osoro, Charles-Antoine Dutertre, Nicole Tan, Shou Kit Hang, Smrithi Hariharaputran, David C. Lye, Amy Herman-Roloff, Nina Le Bert, Antonio Bertoletti |
22 |
[GO] |
2023―Apr―27 |
Machine learning links unresolving secondary pneumonia to mortality in patients with severe pneumonia, including COVID-19 |
Catherine A. Gao, Nikolay S. Markov, Thomas Stoeger, Anna E. Pawlowski, Mengjia Kang, Prasanth Nannapaneni, et al. (+14) Rogan A. Grant, Chiagozie Pickens, James M. Walter, Jacqueline M. Kruser, Luke V. Rasmussen, Daniel Schneider, Justin Starren, Helen K. Donnelly, Alvaro Donayre, Yuan Luo, G.R. Scott Budinger, Richard G. Wunderink, Alexander V. Misharin, Benjamin D. Singer |
23 |
[GO] |
2023―Apr―27 |
C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps |
Bruna M.S. Silva, Giovanni F. Gomes, Flavio P. Veras, Seppe Cambier, Gabriel V.L. Silva, Andreza U. Quadros, et al. (+38) Diego B. Caetité, Daniele C. Nascimento, Camila M.S. Silva, Juliana C. Costa Silva, Samara Damasceno, Ayda H. Schneider, Fabio Beretta, Sabrina S. Batah, Icaro M.S. Castro, Isadora M. Paiva, Tamara Rodrigues, Ana Salina, Ronaldo Martins, Guilherme C. Martelossi Cebinelli, Naira L. Bibo, Daniel Macedo de Melo Jorge, Helder I. Nakaya, Dario S. Zamboni, Luiz O. Leiria, Alexandre T. Fabro, José C. Alves-Filho, Eurico Arruda, Paulo Louzada-Junior, Renê D.R. Oliveira, Larissa D. Cunha, Pierre Van Mol, Lore Vanderbeke, Simon Feys, Els Wauters, Laura Brandolini, Andrea Aramini, Fernando Q. Cunha, Jörg Köhl, Marcello Allegretti, Diether Lambrechts, Joost Wauters, Paul Proost, Thiago M. Cunha |
24 |
[GO] |
2023―Apr―16 |
Does the SARS-CoV-2 spike really have an Achilles heel? |
Shiv Pillai |
25 |
[GO] |
2023―Apr―13 |
Biological rhythms in COVID-19 vaccine effectiveness in an observational cohort study of 1.5 million patients |
Guy Hazan, Or A. Duek, Hillel Alapi, Huram Mok, Alexander T. Ganninger, Elaine M. Ostendorf, et al. (+4) Carrie Gierasch, Gabriel Chodick, David Greenberg, Jeffrey A. Haspel |
26 |
[GO] |
2023―Mar―23 |
Durability of immune responses to the booster mRNA vaccination against COVID-19 |
Prabhu S Arunachalam, Lilin Lai, Hady Samaha, Yupeng Feng, Mengyun Hu, Harold Sai-yin Hui, et al. (+15) Bushra Wali, Madison L. Ellis, Meredith E. Davis-Gardner, Christopher M. Huerta, Kareem Bechnak, Sarah Bechnak, Matthew Lee, Matthew B. Litvack, Cecilia Losada, Alba Grifoni, Alessandro Sette, Veronika I. Zarnitsyna, Nadine Rouphael, Mehul S. Suthar, Bali Pulendran |
27 |
[GO] |
2023―Mar―14 |
SARS-CoV-2 variants resistant to monoclonal antibodies in immunocompromised patients is a public health concern |
Arturo Casadevall, Daniele Focosi |
28 |
[GO] |
2023―Mar―02 |
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody to antigenically distinct Omicron subvariants |
Siriruk Changrob, Peter J. Halfmann, Hejun Liu, Jonathan L. Torres, Joshua J.C. McGrath, Gabriel Ozorowski, et al. (+21) Lei Li, G. Dewey Wilbanks, Makoto Kuroda, Tadashi Maemura, Min Huang, Nai-Ying Zheng, Hannah L. Turner, Steven A. Erickson, Yanbin Fu, Atsuhiro Yasuhara, Gagandeep Singh, Brian Monahan, Jacob Mauldin, Komal Srivastava, Viviana Simon, Florian Krammer, D. Noah Sather, Andrew B Ward, Ian A. Wilson, Yoshihiro Kawaoka, Patrick C. Wilson |
29 |
[GO] |
2023―Feb―23 |
Therapeutic potential of convalescent plasma and SARS-CoV-2 hyperimmune immunoglobulins against BQ.1, BQ.1.1 and XBB variants |
Lorenza Bellusci, Hana Golding, Surender Khurana |
30 |
[GO] |
2023―Feb―02 |
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments |
Akshita Gupta, Angelina Konnova, Mathias Smet, Matilda Berkell, Alessia Savoldi, Matteo Morra, et al. (+10) Vincent Van averbeke, Fien H.R. De Winter, Denise Peserico, Elisa Danese, An Hotterbeekx, Elda Righi, Pasquale De Nardo, Evelina Tacconelli, Surbhi Malhotra-Kumar, Samir Kumar-Singh |
31 |
[GO] |
2023―Jan―31 |
Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs |
Jean-Laurent Casanova, Mark S. Anderson |
32 |
[GO] |
2023―Jan―16 |
Beyond adaptive immunity: induction of trained immunity by COVID-19 adenoviral vaccines |
Mihai G. Netea, Leo A.B. Joosten |
33 |
[GO] |
2023―Jan―02 |
Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity |
Muriel Aguilar-Bretones, Ron A.M. Fouchier, Marion P.G. Koopmans, Gijsbert P. van Nierop |
34 |
[GO] |
2022―Dec―01 |
Impact of pre-existing chronic viral infection and reactivation on the development of long COVID |
Michael J. Peluso, Tyler-Marie Deveau, Sadie E. Munter, Dylan M. Ryder, Amanda M. Buck, Gabriele Beck-Engeser, et al. (+26) Fay Chan, Scott Lu, Sarah A. Goldberg, Rebecca Hoh, Viva Tai, Leonel Torres, Nikita S. Iyer, Monika Deswal, Lynn H. Ngo, Melissa Buitrago, Antonio E. Rodriguez, Jessica Y. Chen, Brandon C. Yee, Ahmed Chenna, John W. Winslow, Christos J. Petropoulos, Amelia N. Deitchman, Joanna Hellmuth, Matthew A. Spinelli, Matthew S. Durstenfeld, Priscilla Y. Hsue, John Daniel Kelly, Jeffrey N. Martin, Steven G. Deeks, Peter W. Hunt, Timothy J. Henrich |
35 |
[GO] |
2022―Nov―30 |
Omicron infection elicits a broad neutralizing response in hospitalized patients with COVID-19 |
Elizabeth M. McNally |
36 |
[GO] |
2022―Nov―03 |
One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients |
Sixten Körper, Beate Grüner, Daniel Zickler, Thomas Wiesmann, Patrick Wuchter, Rainer Blasczyk, et al. (+34) Kai Zacharowski, Peter Spieth, Torsten Tonn, Peter Rosenberger, Gregor Paul, Jan Pilch, Joachim Schwäble, Tamam Bakchoul, Thomas Thiele, Julian Knoerlein, Matthias M. Dollinger, Joerg Krebs, Martin Bentz, Victor M. Corman, Dzenan Kilalic, Gerlinde Schmidtke-Schrezenmeier, Philipp M. Lepper, Lucas Ernst, Hinnerk Wulf, Alexandra Ulrich, Manfred Weiss, Jan Kruse, Thomas Burkhardt, Rebecca Müller, Harald Klüter, Michael Schmidt, Bernd Jahrsdörfer, Ramin Lotfi, Markus Rojewski, Thomas Appl, Benjamin Mayer, Philipp Schnecko, Erhard Seifried, Hubert Schrezenmeier |
37 |
[GO] |
2022―Oct―27 |
Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity |
Christian Meyer zu Natrup, Alina Tscherne, Christine Dahlke, Malgorzata Ciurkiewicz, Dai-Lun Shin, Anahita Fathi, et al. (+27) Cornelius Rohde, Georgia Kalodimou, Sandro Halwe, Leonard Limpinsel, Jan H. Schwarz, Martha Klug, Meral Esen, Nicole Schneiderhan-Marra, Alex Dulovic, Alexandra Kupke, Katrin Brosinski, Sabrina Clever, Lisa-Marie Schünemann, Georg Beythien, Federico Armando, Leonie Mayer, Leonie M. Weskamm, Sylvia Jany, Astrid Freudenstein, Tamara Tuchel, Wolfgang Baumgärtner, Peter Kremsner, Rolf Fendel, Marylyn M. Addo, Stephan Becker, Gerd Sutter, Asisa Volz |
38 |
[GO] |
2022―Oct―25 |
Trained immunity is induced in humans after immunization with an adenoviral vector COVID-19 vaccine |
Dearbhla M. Murphy, Donal J. Cox, Sarah A. Connolly, Eamon P Breen, Aenea A.I. Brugman, James J. Phelan, et al. (+2) Joseph Keane, Sharee A. Basdeo |
39 |
[GO] |
2022―Oct―25 |
The Notch1/CD22 signaling axis disrupts Treg cell function in SARS-CoV2-associated multisystem inflammatory syndrome in children |
Mehdi Benamar, Qian Chen, Janet Chou, Amélie M. Julé, Rafik Boudra, Paola Contini, et al. (+44) Elena Crestani, Peggy S. Lai, Muyun Wang, Jason Fong, Shira Rockwitz, Pui Y. Lee, Tsz Man Fion Chan, Ekin Zeynep Altun, Eda Kepenekli, Elif Karakoc-Aydiner, Ahmet Ozen, Perran Boran, Fatih Aygun, Pınar Önal, Ayse Ayzit Kilinc Sakalli, Haluk Cokugras, Metin Yusuf Gelmez, Fatma B. Oktelik, Esin Cetin Aktas, Yuelin Zhong, Maria L. Taylor, Katherine Irby, Natasha B. Halasa, Elizabeth H. Mack, Sara Signa, Ignazia Prigione, Marco Gattorno, Nicola Cotugno, Donato Amodio, Raif S. Geha, Mary Beth Son, Jane W. Newburger, Pankaj B. Agrawal, Stefano Volpi, Paolo Palma, Ayca Kiykim, Adrienne Randolph, Gunnur Deniz, Safa Baris, Raffaele De Palma, Klaus Schmitz-Abe, Louis-Marie Charbonnier, Lauren A. Henderson, Talal A. Chatila |
40 |
[GO] |
2022―Oct―20 |
Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2 |
Guoli Shi, Abhilash I. Chiramel, Tiansheng Li, Kin Kui Lai, Adam D. Kenney, Ashley Zani, et al. (+10) Adrian C Eddy, Saliha Majdoul, Lizhi Zhang, Tirhas Dempsey, Paul A. Beare, Swagata Kar, Jonathan W. Yewdell, Sonja M Best, Jacob S. Yount, Alex A. Compton |
41 |
[GO] |
2022―Oct―18 |
Neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta or Omicron infection |
Susanne L. Linderman, Lilin Lai, Estefany L. Bocangel Gamarra, Max S.Y. Lau, Srilatha Edupuganti, Diya Surie, et al. (+16) Mark W. Tenforde, James D. Chappell, Nicholas M. Mohr, Kevin W. Gibbs, Jay S. Steingrub, Matthew C. Exline, Nathan I. Shapiro, Anne E. Frosch, Nida Qadir, Meredith E. Davis-Gardner, M. Juliana McElrath, Adam S. Lauring, Mehul S. Suthar, Manish M. Patel, Wesley H. Self, Rafi Ahmed |
42 |
[GO] |
2022―Oct―11 |
Improved control of SARS-CoV-2 by treatment with nucleocapsid-specific monoclonal antibody |
Tanushree Dangi, Sarah Sanchez, Jacob Class, Michelle C. Richner, Lavanya Visvabharathy, Young Rock Chung, et al. (+5) Kirsten Bentley, Richard J. Stanton, Igor J. Koralnik, Justin M. Richner, Pablo Penaloza-MacMaster |
43 |
[GO] |
2022―Sep―27 |
Recognizing the importance of COVID-19 data wrangling |
Laura J. Rasmussen-Torvik |
44 |
[GO] |
2022―Sep―14 |
Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months |
Magdalena E. Sobieszczyk, Jill Maaske, Ann R. Falsey, Stephanie Sproule, Merlin L. Robb, Robert W. Frenck, et al. (+17) Hong-Van Tieu, Kenneth H. Mayer, Lawrence Corey, Kathleen M. Neuzil, Tina Tong, Margaret Brewinski Isaacs, Holly Janes, Himanshu Bansal, Lindsay M. Edwards, Justin A. Green, Elizabeth J. Kelly, Kathryn Shoemaker, Therese Takas, Tom White, Prakash Bhuyan, Tonya Villafana, and Ian Hirsch |
45 |
[GO] |
2022―Sep―14 |
Lessons from a large-scale COVID-19 vaccine trial |
Ranjeet Singh Mahla, Lynn B. Dustin |
46 |
[GO] |
2022―Aug―31 |
COVID-19 vaccines protect children of all ages |
Justin Z. Amarin, Haya Hayek, Natasha B. Halasa |
47 |
[GO] |
2022―Aug―09 |
NVX-CoV2373 vaccination induces functional SARS-CoV-2-specific CD4+ and CD8+ T cell responses |
Carolyn Rydyznski Moderbacher, Christina J. Kim, Jose Mateus, Joyce S. Plested, Mingzhu Zhu, Shane Cloney-Clark, et al. (+5) Daniela Weiskopf, Alessandro Sette, Louis Fries, Gregory Glenn, Shane Crotty |
48 |
[GO] |
2022―Jul―31 |
Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches |
Jasimuddin Ahamed, Jeffrey Laurence |
49 |
[GO] |
2022―Jul―14 |
Frequent detection but lack of infectivity of SARS-CoV-2 RNA in pre-symptomatic, infected blood donor plasma |
Paula Saá, Rebecca V. Fink, Sonia Bakkour, Jing Jin, Graham Simmons, Marcus O. Muench, et al. (+19) Hina Dawar, Clara Di Germanio, Alvin J. Hui, David J. Wright, David E. Krysztof, Steven H. Kleinman, Angela Cheung, Theresa Nester, Debra A. Kessler, Rebecca L. Townsend, Bryan R. Spencer, Hany Kamel, Jacquelyn M. Vannoy, Honey Dave, Michael P. Busch, Susan L. Stramer, Mars Stone, Rachael P. Jackman, Philip J. Norris |
50 |
[GO] |
2022―May―10 |
Favorable vaccine-induced SARS-CoV-2 specific T cell response profile in patients undergoing immune-modifying therapies |
Martin Qui, Nina Le Bert, Webber Pak Wo Chan, Malcolm Tan, Shou Kit Hang, Smrithi Hariharaputran, et al. (+7) Jean Xiang Ying Sim, Jenny Guek Hong Low, Weiling Ng, Wei Yee Wan, Tiing Leong Ang, Antonio Bertoletti, Ennaliza Salazar |
51 |
[GO] |
2022―Apr―28 |
Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response |
Maddalena Marconato, Irene A. Abela, Anthony Hauser, Magdalena Schwarzmüller, Rheliana Katzensteiner, Dominique L. Braun, et al. (+17) Selina Epp, Annette Audigé, Jacqueline Weber, Peter Rusert, Emèry Schindler, Chloé Pasin, Emily West, Jürg Böni, Verena Kufner, Michael Huber, Maryam Zaheri, Stefan Schmutz, Beat M. Frey, Roger D. Kouyos, Huldrych F. Günthard, Markus G. Manz, Alexandra Trkola |
52 |
[GO] |
2022―Apr―26 |
An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer |
Naveenchandra Suryadevara, Andrea R. Shiakolas, Laura A. VanBlargan, Elad Binshtein, Rita E. Chen, James Brett Case, et al. (+15) Kevin J. Kramer, Erica C. Armstrong, Luke Myers, Andrew Trivette, Christopher Gainza, Rachel S. Nargi, Christopher N. Selverian, Edgar Davidson, Benjamin J. Doranz, Summer M. Diaz, Laura S Handal, Robert H. Carnahan, Michael S. Diamond, Ivelin S. Georgiev, James E. Crowe Jr. |
53 |
[GO] |
2022―Mar―22 |
A multitope SARS-COV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants |
Chang Yi Wang, Kao-Pin Hwang, Hui-Kai Kuo, Wen-Jiun Peng, Yea-Huei Shen, Be-Sheng Kuo, et al. (+44) Juin-Hua Huang, Hope Liu, Yu-Hsin Ho, Feng Lin, Shuang Ding, Zhi Liu, Huan-Ting Wu, Ching-Tai Huang, Yuarn-Jang Lee, Ming-Che Liu, Yi-Ching Yang, Po-Liang Lu, Hung-Chin Tsai, Chen-Hsiang Lee, Zhi-Yuan Shi, Chun-Eng Liu, Chun-Hsing Liao, Feng-Yee Chang, Hsiang-Cheng Cheng, Fu-Der Wang, Kuo-Liang Hou, Jennifer Cheng, Min-Sheng Wang, Ya-Ting Yang, Han-Chen Chiu, Ming-Han Jiang, Hao-Yu Shih, Hsuan-Yu Shen, Po-Yen Chang, Yu-Rou Lan, Chi-Tian Chen, Yi-Ling Lin, Jian-Jong Liang, Chun-Che Liao, Yu-Chi Chou, Mary Kate Morris, Carl V. Hanson, Farshad Guirakhoo, Michael Hellerstein, Hui Jing Yu, Chwan-Chuen King, Tracy Kemp, D. Gray Heppner, Thomas P. Monath |
54 |
[GO] |
2022―Mar―08 |
Vaccine-breakthrough infections with SARS-CoV-2 Alpha mirror mutations in Delta Plus, Iota and Omicron |
Brenda Martínez-González, Lucía Vázquez-Sirvent, María E. Soria, Pablo Mínguez, Llanos Salar-Vidal, Carlos García-Crespo, et al. (+13) Isabel Gallego, Ana Ávila, Carlos Llorens, Beatriz Soriano, Ricardo Ramos-Ruiz, Jaime Esteban, Ricardo Fernandez-Roblas, Ignacio Gadea, Carmen Ayuso, Javier Ruiz-Hornillos, Concepción Pérez-Jorge, Esteban Domingo, Celia Perales |
55 |
[GO] |
2022―Feb―09 |
Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2 |
Elena Mitsi, Jesús Reiné, Britta C. Urban, Carla Solorzano, Elissavet Nikolaou, Angela D. Hyder-Wright, et al. (+24) Sherin Pojar, Ashleigh Howard, Lisa Hitchins, Sharon Glynn, Madlen C Farrar, Konstantinos Liatsikos, Andrea M. Collins, Naomi F. Walker, Helen C. Hill, Esther L. German, Katerina S. Cheliotis, Rachel L. Byrne, Christopher T Williams, Ana I. Cubas-Atienzar, Tom E. Fletcher, Emily R. Adams, Simon J. Draper, David Pulido, Rohini Beavon, Christian Theilacker, Elizabeth Begier, Luis Jodar, Bradford D. Gessner, Daniela M. Ferreira |
56 |
[GO] |
2022―Feb―09 |
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes: implications for booster strategies |
Alessio Mazzoni, Anna Vanni, Michele Spinicci, Giulia Lamacchia, Seble Tekle Kiros, Arianna Rocca, et al. (+15) Manuela Capone, Nicoletta Lauria, Lorenzo Salvati, Alberto Carnasciali, Elisabetta Mantengoli, Parham Farahvachi, Lorenzo Zammarchi, Filippo Lagi, Maria Grazia Colao, Francesco Liotta, Lorenzo Cosmi, Laura Maggi, Alessandro Bartoloni, Gian Maria Rossolini, Francesco Annunziato |
57 |
[GO] |
2022―Feb―02 |
Ultrapotent neutralizing antibodies against SARS-CoV-2 with a high degree of mutation resistance |
Jia Zou, Li Li, Peiyi Zheng, Wenhua Liang, Siyi Hu, Shuaixiang Zhou, et al. (+28) Yanqun Wang, Jincun Zhao, Daopeng Yuan, Lu Liu, Dongdong Wu, Mengqiu Xu, Fangfang Zhang, Mengzhu Zhu, Zhihai Wu, Xiaochao Cao, Meng Ni, Xiaomin Ling, Yue Wu, Zhihui Kuang, Moyan Hu, Jianfeng Li, Xue Li, Xiling Guo, Tianmin Xu, Haiping Jiang, Changshou Gao, Michael Yu, Junjian Liu, Nanshan Zhong, Jianfeng Zhou, Jian-an Huang, Tengchuan Jin, Jianxing He |
58 |
[GO] |
2022―Jan―21 |
CD4+ T-cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses |
Bezawit A. Woldemeskel, Arbor G. Dykema, Caroline Garliss, Saphira Cherfils, Kellie N. Smith, Joel N. Blankson |
59 |
[GO] |
2021―Dec―29 |
Platelets mediate inflammatory monocyte activation by SARS-CoV-2 Spike protein |
Tianyang Li, Yang Yang, Yongqi Li, Zhengmin Wang, Faxiang Ma, Runqi Luo, et al. (+7) Xiaoming Xu, Guo Zhou, Jianhua Wang, Junqi Niu, Guoyue Lv, Ian N Crispe, Zhengkun Tu |
60 |
[GO] |
2021―Dec―14 |
The Journal of Clinical Investigation in the time of COVID-19 |
Arturo Casadevall, Sarah Jackson, Gregg L. Semenza, Gordon F. Tomaselli, Rexford S. Ahima |
61 |
[GO] |
2021―Dec―14 |
Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions. Reply. |
Anthony T. Tan, Nina Le Bert, Antonio Bertoletti |
62 |
[GO] |
2021―Dec―14 |
Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions |
Rory D. de Vries, Marieke van der Heiden, Daryl Geers, Celine Imhof, Debbie van Baarle |
63 |
[GO] |
2021―Dec―06 |
Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome |
David S. Perlin, Garry A. Neil, Colleen Anderson, Inbal Zafir-Lavie, Shane Raines, Carl F. Ware, H. Jeffrey Wilkins |
64 |
[GO] |
2021―Nov―29 |
SARS-CoV-2-specific memory B cells can persist in the elderly who have lost detectable neutralising antibodies |
Anna Jeffery-Smith, Alice R. Burton, Sabela Lens, Chloe Rees-Spear, Jessica Davies, Monika Patel, et al. (+9) Robin Gopal, Luke Muir, Felicity Aiano, Katie J. Doores, J. Yimmy Chow, Shamez N. Ladhani, Maria Zambon, Laura E. McCoy, Mala K. Maini. |
65 |
[GO] |
2021―Nov―17 |
A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia |
Katharine J. Bar, Pamela A. Shaw, Grace H. Choi, Nicole Aqui, Andrew Fesnak, Jasper B. Yang, et al. (+34) Haideliza Soto-Calderon, Lizette Grajales, Julie Starr, Michelle Andronov, Miranda Mastellone, Chigozie Amonu, Geoff Feret, Maureen DeMarshall, Marie Buchanan, Maria Caturla, James Gordon, Alan Wanicur, M. Alexandra Monroy, Felicity Mampe, Emily Lindemuth, Sigrid Gouma, Anne M. Mullin, Holly Barilla, Anastasiya Pronina, Leah Irwin, Raeann Thomas, Risa A. Eichinger, Faye Demuth, Eline T. Luning Prak, Jose L. Pascual, William R. Short, Michal A. Elovitz, Jillian Baron, Nuala J. Meyer, Kathleen O. Degnan, Ian Frank, Scott E. Hensley, Donald L. Siegel, Pablo Tebas |
66 |
[GO] |
2021―Nov―14 |
Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone |
Peter J. Siska, Sonja-Maria Decking, Nathalie Babl, Carina Matos, Christina Bruss, Katrin Singer, et al. (+40) Jana Klitzke, Marian Schön, Jakob Simeth, Josef Köstler, Heiko Siegmund, Ines Ugele, Michael Paulus, Alexander Dietl, Kristina Kolodova, Louisa Steines, Katharina Freitag, Alice Peuker, Gabriele Schönhammer, Johanna Raithel, Bernhard Graf, Florian Geismann, Matthias Lubnow, Matthias Mack, Peter Hau, Christopher Bohr, Ralph Burkhardt, Andre Gessner, Bernd Salzberger, Ralf Wagner, Frank Hanses, Florian Hitzenbichler, Daniel Heudobler, Florian Lüke, Tobias Pukrop, Wolfgang Herr, Daniel Wolff, Rainer Spang, Hendrik Poeck, Petra Hoffmann, Jonathan Jantsch, Christoph Brochhausen, Dirk Lunz, Michael Rehli, Marina Kreutz, Kathrin Renner |
67 |
[GO] |
2021―Nov―09 |
Family matters for coronavirus disease and vaccines |
David J. Bean, Manish Sagar |
68 |
[GO] |
2021―Oct―31 |
NK cell receptor and ligand composition influences the clearance of SARS-CoV-2 |
Wan-Chen Hsieh, En-Yu Lai, Yu-Ting Liu, Yi-Fu Wang, Yi-Shiuan Tzeng, Lu Cui, et al. (+22) Yun-Ju Lai, Hsiang-Chi Huang, Jia-Hsin Huang, Hung-Chih Ni, Dong-Yan Tsai, Jian-Jong Liang, Chun-Che Liao, Ya-Ting Lu, Laurence Jiang, Ming-Tsan Liu, Jann-Tay Wang, Sui-Yuan Chang, Chung-Yu Chen, Hsing-Chen Tsai, Yao-Ming Chang, Gerlinde Wernig, Chia-Wei Li, Kuo-I Lin, Yi-Ling Lin, Huai-Kuang Tsai, Yen-Tsung Huang, Shih-Yu Chen |
69 |
[GO] |
2021―Oct―28 |
The intersection of COVID-19 and autoimmunity |
Jason S. Knight, Roberto Caricchio, Jean Laurent Casanova, Alexis J. Combes, Betty Diamond, Sharon E. Fox, et al. (+13) David A. Hanauer, Judith A. James, Yogendra Kanthi, Virginia Ladd, Puja Mehta, Aaron M. Ring, Ignacio Sanz, Carlo Selmi, Russell P. Tracy, Paul J. Utz, Catriona A. Wagner, Julia Y. Wang, W. Joseph McCune |
70 |
[GO] |
2021―Oct―21 |
Will GWAS eventually allow the identification of genomic biomarkers for COVID-19 severity and mortality? |
Vito Luigi Colona, Michela Bianocolella, Antonio Novelli, Giuseppe Novelli |
71 |
[GO] |
2021―Oct―08 |
Cross-protective immunity following coronavirus vaccination and coronavirus infection |
Tanushree Dangi, Nicole Palacio, Sarah Sanchez, Mincheol Park, Jake Class, Lavanya Visvabharathy, et al. (+4) Thomas Ciucci, Igor J. Koralnik, Justin M. Richner, Pablo Penaloza-MacMaster |
72 |
[GO] |
2021―Oct―07 |
SARS-CoV-2 vaccine effectiveness in preventing confirmed infection in pregnant women |
Adeel A. Butt, Hiam Chemaitelly, Abdullatif Al Khal, Peter V Coyle, Huda Saleh, Anvar Kaleeckal, et al. (+4) Ali N. Latif, Roberto Bertollini, Abdul Badi Abou-Samra, Laith J. Abu-Raddad |
73 |
[GO] |
2021―Oct―01 |
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality |
Tomoko Nakanishi, Sara Pigazzini, Frauke Degenhardt, Mattia Cordioli, Guillaume Butler-Laporte, Douglas Maya-Miles, et al. (+41) Luis Bujanda, Youssef Bouysran, Mari E.K. Niemi, Adriana Palom, David Ellinghaus, Atlas Khan, Manuel Martínez-Bueno, Selina Rolker, Sara Amitrano, Luisa Roade Tato, Francesca Fava, Christoph D. Spinner, Daniele Prati, David Bernardo, Federico Garcia, Gilles Darcis, Israel Fernandez-Cadenas, Jan Cato Holter, Jesus M. Banales, Robert Frithiof, Krzysztof Kiryluk, Stefano Duga, Rosanna Asselta, Alexandre C. Pereira, Manuel Romero-Gómez, Beatriz Nafría-Jiménez, Johannes R. Hov, Isabelle Migeotte, Alessandra Renieri, Anna M. Planas, Kerstin U. Ludwig, Maria Buti, Souad Rahmouni, Marta E. Alarcón-Riquelme, Eva C. Schulte, Andre Franke, Tom H. Karlsen, Luca Valenti, Hugo Zeberg, J. Brent Richards, Andrea Ganna |
74 |
[GO] |
2021―Sep―30 |
Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine |
Ofer Beharier, Romina Plitman Mayo, Tal Raz, Kira Nahum Sacks, Letizia Schreiber, Yael Suissa-Cohen, et al. (+18) Rony Chen, Rachel Gomez-Tolub, Eran Hadar, Rinat Gabbay-Benziv, Yuval Jaffe Moshkovich, Tal Biron-Shental, Gil Shechter-Maor, Sivan Farladansky-Gershnabel, Hen Yitzhak Sela, Hedi Benyamini-Raischer, Nitzan D. Sela, Debra Goldman-Wohl, Ziv Shulman, Ariel Many, Haim Barr, Simcha Yagel, Michal Neeman, Michal Kovo |
75 |
[GO] |
2021―Sep―14 |
Physician-scientists in the pandemic era: tidal wave or rising tide? |
Lorraine B. Ware |
76 |
[GO] |
2021―Sep―09 |
Seasonal coronavirus-specific B-cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19 patients |
Muriel Aguilar-Bretones, Brenda M. Westerhuis, Matthijs P. Raadsen, Erwin de Bruin, Felicity D. Chandler, Nisreen M.A. Okba, et al. (+12) Bart L. Haagmans, Thomas Langerak, Henrik Endeman, Johannes P.C. van den Akker, Diederik A.M.P.J. Gommers, Eric C.M. van Gorp, Corine H. GeurtsvanKessel, Rory D. de Vries, Ron A.M. Fouchier, Barry H.G. Rockx, Marion P.G. Koopmans, Gijsbert P. van Nierop |
77 |
[GO] |
2021―Sep―02 |
A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia |
Cristina Avendaño-Solá, Antonio Ramos-Martínez, Elena Muñez-Rubio, Belen Ruiz-Antorán, Rosa Malo de Molina, Ferran Torres, et al. (+31) Ana Fernández-Cruz, Jorge Calderon-Parra, Concepcion Payares-Herrera, Alberto Díaz de Santiago, Irene Romera Martínez, Ilduara Pintos, Jaime Lora-Tamayo, Mikel Mancheño-Losa, Maria Liz Paciello Coronel, AL Martinez-Gonzalez, Julia Vidán-Estévez, Maria José Nuñez-Orantos, Maria Isabel Saez-Serrano, Maria Lourdes Porras-Leal, Maria del Castillo Jarilla-Fernández, Paula Villares, Jaime Perez de Oteyza, Ascensión Ramos-Garrido, Lydia Blanco, Maria Elena Madrigal-Sánchez, Martín Rubio-Batllés, Ana Velasco-Iglesias, José Ramón Paño-Pardo, JA Moreno-Chulilla, Eduardo Muñiz-Diaz, Inmaculada Casas-Flecha, Mayte Pérez-Olmeda, Javier García-Pérez, Jose Alcami, José Luis Bueno, Rafael F. Duarte |
78 |
[GO] |
2021―Aug―31 |
Convalescent plasma associates with reduced mortality and improved clinical trajectory in patients hospitalized with COVID-19 |
Shanna A. Arnold Egloff, Angela Junglen, Joseph S.A. Restivo, Marjorie Wongskhaluang, Casey Martin, Pratik Doshi, et al. (+6) Daniel Schlauch, Gregg Fromell, Lindsay E. Sears, Mick Correll, Howard A. Burris, Charles F. LeMaistre |
79 |
[GO] |
2021―Aug―31 |
Results of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients |
Sixten Körper, Manfred Weiss, Daniel Zickler, Thomas Wiesmann, Kai Zacharowski, Victor M. Corman, et al. (+21) Beate Grüner, Lucas Ernst, Peter Spieth, Philipp M. Lepper, Martin Bentz, Sebastian Zinn, Gregor Paul, Johannes Kalbhenn, Matthias M. Dollinger, Peter Rosenberger, Thomas Kirschning, Thomas Thiele, Thomas Appl, Benjamin Mayer, Michael Schmidt, Christian Drosten, Hinnerk Wulf, Jan Matthias Kruse, Bettina Jungwirth, Erhard Seifried, Hubert Schrezenmeier |
80 |
[GO] |
2021―Aug―31 |
Rapid measurement of SARS-CoV-2 spike T cells in whole blood from vaccinated and naturally infected individuals |
Anthony T. Tan, Joey M.E. Lim, Nina Le Bert, Kamini Kunasegaran, Adeline Chia, Martin D.C. Qui, et al. (+12) Nicole Tan, Wan Ni Chia, Ruklanthi de Alwis, Ding Ying, Jean X.Y. Sim, Eng Eong Ooi, Lin-Fa Wang, Mark I-Cheng Chen, Barnaby E. Young, Jenny G.H. Low, David C. Lye, Antonio Bertoletti |
81 |
[GO] |
2021―Aug―27 |
Attenuated activation of pulmonary immune cells in mRNA-1273 vaccinated hamsters after SARS-CoV-2 infection |
Michelle Meyer, Yuan Wang, Darin Edwards, Gregory R. Smith, Aliza B. Rubenstein, Palaniappan Ramanathan, et al. (+22) Chad E. Mire, Colette Pietzsch, Xi Chen, Yongchao Ge, Wan Sze Cheng, Carole Henry, Angela Woods, LingZhi Ma, Guillaume B.E. Stewart-Jones, Kevin W. Bock, Mahnaz Minai, Bianca M. Nagata, Sivakumar Periasamy, Pei-Yong Shi, Barney S. Graham, Ian N. Moore, Irene Ramos, Olga G. Troyanskaya, Elena Zaslavsky, Andrea Carfi, Stuart C. Sealfon, Alexander Bukreyev |
82 |
[GO] |
2021―Aug―19 |
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19 |
Ravindra Ganesh, Colin F. Pawlowski, John C. O'Horo, Lori L. Arndt, Richard F. Arndt, Sarah Bell, et al. (+14) Dennis M. Bierle, Molly Destro Borgen, Sara Hanson, Alexander Heyliger, Jennifer L. Larsen, Patrick J. Lenehan, Robert Orenstein, Arjun Puranik, Leigh L. Speicher, Sidna M. Tulledge-Scheitel, AJ Venkatakrishnan, Caroline G. Wilker, Andrew D. Badley, Raymund R. Razonable |
83 |
[GO] |
2021―Aug―19 |
Association of in-hospital use of ACE-I/ARB and COVID-19 outcomes in African American population |
Shilong Li, Rangaprasad Sarangarajan, Tomi Jun, Yu-Han Kao, Zichen Wang, Ke Hao, et al. (+7) Emilio Schadt, Michael A. Kiebish, Elder Granger, Niven R. Narain, Rong Chen, Eric E. Schadt, Li Li |
84 |
[GO] |
2021―Aug―17 |
Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality |
Justin M. Snider, Jeehyun Karen You, Xia Wang, Ashley J. Snider, Brian Hallmark, Manja M. Zec, et al. (+18) Michael C. Seeds, Susan Sergeant, Laurel Johnstone, Qiuming Wang, Ryan Sprissler, Tara F. Carr, Karen Lutrick, Sairam Parthasarathy, Christian Bime, Hao H. Zhang, Chiara Luberto, Richard R. Kew, Yusuf A. Hannun, Stefano Guerra, Charles E. McCall, Guang Yao, Maurizio Del Poeta, Floyd H. Chilton |
85 |
[GO] |
2021―Aug―10 |
Dominance of alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City |
Ralf Duerr, Dacia Dimartino, Christian Marier, Paul Zappile, Guiqing Wang, Jennifer Lighter, et al. (+3) Brian Elbel, Andrea B. Troxel, Adriana Heguy |
86 |
[GO] |
2021―Jul―14 |
Distinctive features of severe SARS-CoV-2 pneumonia |
G.R. Scott Budinger, Alexander V. Misharin, Karen M. Ridge, Benjamin D. Singer, Richard G. Wunderink |
87 |
[GO] |
2021―Jun―30 |
SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes |
Yijia Li, Alexis M. Schneider, Arnav Mehta, Moshe Sade-Feldman, Kyle R. Kays, Matteo Gentili, et al. (+24) Nicole C. Charland, Anna L.K. Gonye, Irena Gushterova, Hargun K. Khanna, Thomas J. LaSalle, Kendall M. Lavin-Parsons, Brendan M. Lilley, Carl L. Lodenstein, Kasidet Manakongtreecheep, Justin D. Margolin, Brenna N. McKaig, Blair A. Parry, Maricarmen Rojas-Lopez, Brian C. Russo, Nihaarika Sharma, Jessica Tantivit, Molly F. Thomas, James Regan, James P. Flynn, Alexandra-Chloé Villani, Nir Hacohen, Marcia B. Goldberg, Michael R. Filbin, Jonathan Z. Li |
88 |
[GO] |
2021―Jun―24 |
Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia |
Qian Zhang, Aurélie Cobat, Paul Bastard, Luigi D. Notarangelo, Helen C. Su, Laurent Abel, Jean-Laurent Casanova |
89 |
[GO] |
2021―Jun―22 |
Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia. Reply |
Gundula Povysil, Guillaume Butler-Laporte, Ali G. Gharavi, J. Brent Richards, David B. Goldstein, Krzysztof Kiryluk |
90 |
[GO] |
2021―Jun―18 |
Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid organ transplant recipients |
Peter G. Stock, Timothy J. Henrich, Dorry L. Segev, William A. Werbel |
91 |
[GO] |
2021―Jun―08 |
Impaired humoral and cellular immunity after SARS-CoV2 BNT162b2 (Tozinameran) prime-boost vaccination in kidney transplant recipients |
Arne Sattler, Eva Schrezenmeier, Ulrike A. Weber, Alexander Potekhin, Friederike Bachmann, Henriette Straub-Hohenbleicher, et al. (+19) Klemens Budde, Elena Storz, Vanessa Proß, Yasmin Bergmann, Linda M.L. Thole, Caroline Tizian, Oliver Hölsken, Andreas Diefenbach, Hubert Schrezenmeier, Bernd Jahrsdörfer, Tomasz Zemojtel, Katharina Jechow, Christian Conrad, Sören Lukassen, Diana Stauch, Nils Lachmann, Mira Choi, Fabian Halleck, Katja Kotsch |
92 |
[GO] |
2021―Jun―01 |
Coronavirus-specific antibody production in middle-aged mice requires phospholipase A2G2D |
Jian Zheng, David Meyerholz, Lok-Yin Roy Wong, Michael Gelb, Makoto Murakami, Stanley Perlman |
93 |
[GO] |
2021―Jun―01 |
Mild COVID-19 despite autoantibodies to type I IFNs in Autoimmune-Polyendocrine-Syndrome Type 1 (APS-1) |
Christian Meisel, Bengisu Akbil, Tim Meyer, Erwin Lankes, Victor M. Corman, Olga Staudacher, et al. (+8) Nadine Unterwalder, Uwe Kölsch, Christian Drosten, Marcus A. Mall, Tilmann Kallinich, Dirk Schnabel, Christine Goffinet, Horst von Bernuth |
94 |
[GO] |
2021―Jun―01 |
Do monogenic inborn errors of immunity cause susceptibility to severe COVID-19? |
Chris Cotsapas, Janna Saarela, Jocelyn R. Farmer, Vinod Scaria, Roshini S. Abraham |
95 |
[GO] |
2021―May―27 |
Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19 |
Gundula Povysil, Guillaume Butler-Laporte, Ning Shang, Chen Wang, Atlas Khan, Manal Alaamery, et al. (+46) Tomoko Nakanishi, Sirui Zhou, Vincenzo Forgetta, Robert J. M. Eveleigh, Mathieu Bourgey, Naveed Aziz, Steven J.M. Jones, Bartha Knoppers, Stephen W. Scherer, Lisa J. Strug, Pierre Lepage, Jiannis Ragoussis, Guillaume Bourque, Jahad Alghamdi, Nora Aljawini, Nour Albesher, Hani M. Al-Afghani, Bader Alghamdi, Mansour S. Almutair, Ebrahim Sabri Mahmoud, Leen Abu-Safieh, Hadeel El Bardisy, Fawz S. Al Harthi, Abdulraheem Alshareef, Bandar Ali Suliman, Saleh A. Alqahtani, Abdulaziz Almalik, May M. Alrashed, Salam Massadeh, Vincent Mooser, Mark Lathrop, Mohamed Fawzy, Yaseen M. Arabi, Hamdi Mbarek, Chadi Saad, Wadha Al-Muftah, Junghyun Jung, Serghei Mangul, Radja Badji, Asma Al Thani, Said I. Ismail, Ali G. Gharavi, Malak S. Abedalthagafi, J Brent Richards, David B. Goldstein, Krzysztof Kiryluk |
96 |
[GO] |
2021―May―21 |
Mounting evidence for immunizing previously infected subjects with a single dose of SARS-CoV-2 vaccine |
Gonzalo Perez Marc, Damian Alvarez-Paggi, Fernando P. Polack |
97 |
[GO] |
2021―May―20 |
Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine |
Ofer Beharier, Romina Plitman Mayo, Tal Raz, Kira Nahum Sacks, Letizia Schreiber, Yael Suissa-Cohen, et al. (+18) Rony Chen, Rachel Gomez-Tolub, Eran Hadar, Rinat Gabbay-Benziv, Yuval Jaffe Moshkovich, Tal Biron-Shental, Gil Shechter-Maor, Sivan Farladansky-Gershnabel, Hen Yitzhak Sela, Hedi Benyamini-Raischer, Nitzan D. Sela, Debra Goldman-Wohl, Ziv Shulman, Ariel Many, Haim Barr, Simcha Yagel, Michal Neeman, Michal Kovo |
98 |
[GO] |
2021―May―18 |
Nasal ciliated cells are primary targets for SARS-CoV-2 replication in early stage of COVID-19 |
Ji Hoon Ahn, JungMo Kim, Seon Pyo Hong, Sung Yong Choi, Myung Jin Yang, Young Seok Ju, et al. (+8) Young Tae Kim, Ho Min Kim, MD Tazikur Rahman, Man Ki Chung, Sang Duk Hong, Hosung Bae, Chang-Seop Lee, Gou Young Koh |
99 |
[GO] |
2021―May―11 |
A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19 |
Max R. O'Donnell, Beatriz Grinsztejn, Matthew J. Cummings, Jessica E. Justman, Matthew R. Lamb, Christina M. Eckhardt, et al. (+36) Neena M. Philip, Ying Kuen Cheung, Vinay Gupta, Esau João, Jose H. Pilotto, Maria Pia Diniz, Sandra Wagner Cardoso, Darryl Abrams, Kartik N. Rajagopalan, Sarah E. Borden, Allison Wolf, Leon Claude Sidi, Alexandre Vizzoni, Valdilea G. Veloso, Zachary C. Bitan, Dawn E. Scotto, Benjamin J. Meyer, Samuel D. Jacobson, Alex Kantor, Nischay Mishra, Lokendra V. Chauhan, Elizabeth F. Stone, Flavia Dei Zotti, Francesca La Carpia, Krystalyn E. Hudson, Stephen A. Ferrara, Joseph Schwartz, Brie A. Stotler, Wen-Hsuan W. Lin, Sandeep N. Wontakal, Beth Shaz, Thomas Briese, Eldad A. Hod, Steven L. Spitalnik, Andrew Eisenberger, Walter I. Lipkin |
100 |
[GO] |
2021―May―11 |
What should define a SARS-CoV-2 “breakthrough” infection? |
John S. Schieffelin, Elizabeth B. Norton, Jay K. Kolls |
101 |
[GO] |
2021―May―06 |
One dose of SARS-CoV-2 vaccine exponentially increases antibodies in recovered individuals with symptomatic COVID-19 |
Riccardo Levi, Elena Azzolini, Chiara Pozzi, Leonardo Ubaldi, Michele Lagioia, Alberto Mantovani, Maria Rescigno |
102 |
[GO] |
2021―May―04 |
Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and Tuberculosis co-infection |
Catherine Riou, Elsa Du Bruyn, Cari Stek, Remy Daroowala, Rene T. Goliath, Fatima Abrahams, et al. (+8) Qonita Said-Hartley, Brian W. Allwood, Nei-Yuan Hsiao, Katalin A. Wilkinson, Cecilia S. Lindestam Arlehamn, Alessandro Sette, Sean Wasserman, Robert J. Wilkinson |
103 |
[GO] |
2021―May―04 |
Is complement the culprit behind COVID-19 vaccine-related adverse reactions? |
Dimitrios C. Mastellos, Panagiotis Skendros, John D. Lambris |
104 |
[GO] |
2021―May―03 |
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in recovered COVID-19 subjects |
Alessio Mazzoni, Nicoletta Di Lauria, Laura Maggi, Lorenzo Salvati, Anna Vanni, Manuela Capone, et al. (+16) Giulia Lamacchia, Elisabetta Mantengoli, Michele Spinicci, Lorenzo Zammarchi, Seble Tekle Kiros, Arianna Rocca, Filippo Lagi, Maria Grazia Colao, Paola Parronchi, Cristina Scaletti, Lucia Turco, Francesco Liotta, Gian Maria Rossolini, Lorenzo Cosmi, Alessandro Bartoloni, Francesco Annunziato |
105 |
[GO] |
2021―Apr―12 |
SARS-CoV-2 as a superantigen in multisystem inflammatory syndrome in children (MIS-C) |
Theodore Kouo, Worarat Chaisawangwong |
106 |
[GO] |
2021―Apr―12 |
Structure-based phylogeny identifies Avoralstat as a TMPRSS2 inhibitor that prevents SARS-CoV-2 infection in mice |
Young Joo Sun, Gabriel Velez, Dylan E. Parsons, Kun Li, Miguel E. Ortiz, Shaunik Sharma, et al. (+3) Paul B. McCray Jr., Alexander G. Bassuk, Vinit B. Mahajan |
107 |
[GO] |
2021―Apr―08 |
Functional characterization of CD4+ T-cell receptors cross-reactive for SARS-CoV-2 and endemic coronaviruses |
Arbor G. Dykema, Boyang Zhang, Bezawit A. Woldemeskel, Caroline C. Garliss, Laurene S. Cheung, Dilshad Choudhury, et al. (+22) Jiajia Zhang, Luis Aparicio, Sadhana Bom, Rufiaat Rashid, Justina X. Caushi, Emily Han-Chung Hsiue, Katherine Cascino, Elizabeth A. Thompson, Abena K. Kwaa, Dipika Singh, Sampriti Thapa, Alvaro A. Ordonez, Andrew Pekosz, Franco R. D'Alessio, Jonathan D. Powell, Srinivasan Yegnasubramanian, Shibin Zhou, Drew M. Pardoll, Hongkai Ji, Andrea L. Cox, Joel N. Blankson, Kellie N. Smith |
108 |
[GO] |
2021―Apr―06 |
SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63 |
Bezawit A. Woldemeskel, Caroline C. Garliss, Joel N. Blankson |
109 |
[GO] |
2021―Mar―16 |
A sobering addition to the literature on COVID-19 and the brain |
Amit Mahajan, Graeme F. Mason |
110 |
[GO] |
2021―Feb―26 |
Identification of SARS-CoV-2-specific immune alterations in acutely ill patients |
Rose-Marie Rébillard, Marc Charabati, Camille Grasmuck, Abdelali Filali-Mouhim, Olivier Tastet, Nathalie Brassard, et al. (+32) Audrey Daigneault, Lyne Bourbonnière, Sai Priya Anand, Renaud Balthazard, Guillaume Beaudoin-Bussières, Romain Gasser, Mehdi Benlarbi, Ana Carmena Moratalla, Yves Carpentier Solorio, Marianne Boutin, Negar Farzam-kia, Jade Descôteaux-Dinelle, Antoine Philippe Fournier, Elizabeth M. Gowing, Annemarie Laumaea, Hélène Jamann, Boaz Lahav, Guillaume Goyette, Florent Lemaître, Victoria Hannah Mamane, Jérémie Prévost, Jonathan Richard, Karine Thai, Jean-François Cailhier, Nicolas Chomont, Andrés Finzi, Michaël Chassé, Madeleine Durand, Nathalie Arbour, Daniel E. Kaufmann, Alexandre Prat, Catherine Larochelle |
111 |
[GO] |
2021―Feb―25 |
Long-term micro-structure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations |
Yuanyuan Qin, Jinfeng Wu, Tao Chen, Jia Li, Guiling Zhang, Di Wu, et al. (+8) Yiran Zhou, Ning Zheng, Aoling Cai, Qin Ning, Anne Manyande, Fuqiang Xu, Jie Wang, Wenzhen Zhu |
112 |
[GO] |
2021―Feb―23 |
SARS-Cov2 variants and convalescent plasma: reality, fallacies, and opportunities |
Arturo Casadevall, Jeffrey Henderson, Michael Joyner, Liise-anne Pirofski |
113 |
[GO] |
2021―Feb―11 |
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality |
William R. Morgenlander, Stephanie N. Henson, Daniel R. Monaco, Athena Chen, Kirsten Littlefield, Evan M. Bloch, et al. (+23) Eric Fujimura, Ingo Ruczinski, Andrew R. Crowley, Harini Natarajan, Savannah E. Butler, Joshua A. Weiner, Mamie Z. Li, Tania S. Bonny, Sarah E. Benner, Ashwin Balagopal, David Sullivan, Shmuel Shoham, Thomas C. Quinn, Susan Eshleman, Arturo Casadevall, Andrew D. Redd, Oliver Laeyendecker, Margaret E. Ackerman, Andrew Pekosz, Stephen J. Elledge, Matthew L. Robinson, Aaron A.R. Tobian, H. Benjamin Larman |
114 |
[GO] |
2021―Feb―11 |
Durable SARS-CoV-2 B cell immunity after mild or severe disease |
Clinton O. Ogega, Nicole E. Skinner, Paul W. Blair, Han-Sol Park, Kirsten Littlefield, Abhinaya Ganesan, et al. (+10) Santosh Dhakal, Pranay Ladiwala, Annukka A.R. Antar, Stuart C. Ray, Michael J. Betenbaugh, Andrew Pekosz, Sabra L. Klein, Yukari C. Manabe, Andrea L. Cox, Justin R. Bailey |
115 |
[GO] |
2021―Feb―09 |
Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection |
Zhen Huang, Bo Ning, He S. Yang, Brady M. Youngquist, Alex Niu, Christopher J. Lyon, et al. (+19) Brandon J. Beddingfield, Alyssa C. Fears, Chandler H. Monk, Amelie E. Murrell, Samantha J. Bilton, Joshua P. Linhuber, Elizabeth B. Norton, Monika L. Dietrich, Jim K. Yee, Weihua Lai, John W. Scott, Xiao-Ming Yin, Jay Rappaport, James E. Robinson, Nakhle S. Saba, Chad J. Roy, Kevin J. Zwezdaryk, Zhen Zhao, Tony Y. Hu |
116 |
[GO] |
2021―Feb―01 |
The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity |
Hamid Bolouri, Cate Speake, David Skibinski, S. Alice Long, Anne M. Hocking, Daniel J. Campbell, et al. (+3) Jessica A. Hamerman, Uma Malhotra, Jane H. Buckner |
117 |
[GO] |
2021―Jan―26 |
Similarities and differences between the immunopathogenesis of COVID-19-related pediatric inflammatory multisystem syndrome and Kawasaki disease |
Ana Esteve-Sole, Jordi Anton, Rosa Maria Pino-Ramírez, Judith Sanchez-Manubens, Victoria Fumadó, Clàudia Fortuny, et al. (+17) María Rios-Barnes, Joan Sanchez-de-Toledo, Mónica Girona-Alarcón, Juan M. Mosquera, Silvia Ricart, Cristian Launes, Mariona Fernández de Sevilla, Cristina Jou, Carmen Muñoz-Almagro, Eva González-Roca, Andrea Vergara, Jorge Carrillo, Manel Juan, Daniel Cuadras, Antoni Noguera-Julian, Iolanda Jordan, Laia Alsina |
118 |
[GO] |
2021―Jan―26 |
Severe SARS-CoV-2 placenta infection can impact neonatal outcome in the absence of vertical transmission |
Fulvia Milena Cribié, Roberta Erra, Lorenza Pugni, Carlota Rubio-Perez, Lidia Alonso, Sara Simonetti, et al. (+16) Giorgio A. Croci, Garazi Serna, Andrea Ronchi, Carlo Pietrasanta, Giovanna Lunghi, Anna Maria Fagnani, Maria Piñana, Matthias S. Matter, Alexandar Tzankov, Luigi Terracciano, Andres Anton, Enrico Ferrazzi, Stefano Ferrero, Enrico Iurlaro, Joan Seoane, Paolo Nuciforo |
119 |
[GO] |
2021―Jan―25 |
Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity |
Sara Falck-Jones, Sindhu Vangeti, Meng Yu, Ryan Falck-Jones, Alberto Cagigi, Isabella Badolati, et al. (+16) Björn Österberg, Maximilian Julius Lautenbach, Eric Ahlberg, Ang Lin, Rico Lepzien, Inga Szurgot, Klara Lenart, Fredrika Hellgren, Holden T. Maecker, Jörgen Sälde, Jan Albert, Niclas Johansson, Max Bell, Karin Lore, Anna Färnert, Anna Smed-Sörensen |
120 |
[GO] |
2021―Jan―14 |
COVID-19 vaccine testing in pregnant females is necessary |
Sabra L. Klein, Patrick S. Creisher, Irina Burd |
121 |
[GO] |
2021―Jan―11 |
SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals |
Hassen Kared, Andrew D. Redd, Evan M. Bloch, Tania S. Bonny, Hermi R. Sumatoh, Faris Kairi, et al. (+16) Daniel Carbajo, Brian Abel, Evan W. Newell, Maria Bettinotti, Sarah E. Benner, Eshan U. Patel, Kirsten Littlefield, Oliver Laeyendecker, Shmuel Shoham, David Sullivan, Arturo Casadevall, Andrew Pekosz, Alessandra Nardin, Michael Fehlings, Aaron AR Tobian, Thomas C. Quinn |
122 |
[GO] |
2020―Dec―15 |
Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 among COVID-19 convalescent plasma donor candidates |
Jim Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, Danniel Zamora, Sarah A. McGuffin, Adrienne E. Shapiro, et al. (+19) Victoria L. Campbell, Christopher L. McClurkan, Lichen Jing, Robin Gross, Janie Liang, Elena Postnikova, Steven Mazur, Vladimir V. Lukin, Anu Chaudhary, Marie K. Das, Susan L. Fink, Andrew Bryan, Alexander L. Greninger, Keith R. Jerome, Michael R. Holbrook, Terry B. Gernsheimer, Mark H. Wener, Anna Wald, David M. Koelle |
123 |
[GO] |
2020―Dec―11 |
BCG vaccination in healthcare providers and the protection against COVID-19 |
Mihai G. Netea, Jos W.M. van der Meer, Reinout van Crevel |
124 |
[GO] |
2020―Nov―20 |
Does common cold coronavirus infection protect against severe SARS-CoV2 disease? |
David K. Meyerholz, Stanley Perlman |
125 |
[GO] |
2020―Nov―20 |
SARS-CoV-2 B cell receptor signatures in risk populations |
Andrew I. Flyak |
126 |
[GO] |
2020―Nov―19 |
BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of healthcare workers |
Magali Noval Rivas, Joseph E. Ebinger, Min Wu, Nancy Sun, Jonathan Braun, Kimia Sobhani, et al. (+3) Jennifer E. Van Eyk, Susan Cheng, Moshe Arditi |
127 |
[GO] |
2020―Nov―12 |
Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium |
Bryce A. Schuler, A. Christian Habermann, Erin J. Plosa, Chase J. Taylor, Christopher Jetter, Nicholas M. Negretti, et al. (+13) Meghan E. Kapp, John T. Benjamin, Peter Gulleman, David S. Nichols, Lior Z. Braunstein, Alice Hackett, Michael Koval, Susan H. Guttentag, Timothy S. Blackwell, Steven A. Webber, Nicholas E. Banovich, Jonathan A. Kropski, Jennifer M. S. Sucre |
128 |
[GO] |
2020―Nov―10 |
Emergency seed funding for COVID-19 research: lessons from Johns Hopkins University |
Julie Messersmith, Chasmine Stoddart-Osumah, Marc Lennon, Denis Wirtz |
129 |
[GO] |
2020―Nov―02 |
Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome |
Jiao Liu, Sheng Zhang, Xuan Dong, Zhongyi Li, Qianghong Xu, Huibin Feng, et al. (+14) Jing Cai, Sisi Huang, Jun Guo, Lidi Zhang, Yizhu Chen, Wei Zhu, Hangxiang Du, Yongan Liu, Tao Wang, Limin Chen, Zhenliang Wen, Djillali Annane, Jieming Qu, Dechang Chen |
130 |
[GO] |
2020―Oct―29 |
Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection |
Jacob K. Files, Sushma Boppana, Mildred D. Perez, Sanghita Sarkar, Kelsey E. Lowman, Kai Qin, et al. (+9) Sarah Sterrett, Eric Carlin, Anju Bansal, Steffanie Sabbaj, Dustin M. Long, Olaf Kutsch, James Kobie, Paul Goepfert, Nathaniel Erdmann |
131 |
[GO] |
2020―Oct―27 |
Inflammatory syndromes associated with SARS-CoV-2 infection: dysregulation of the immune response across the age spectrum |
Jill E. Weatherhead, Eva H. Clark, Tiphanie P. Vogel, Robert L. Atmar, Prathit A. Kulkarni |
132 |
[GO] |
2020―Oct―26 |
Prolonged adaptive immune activation in COVID-19: implications for maintenance of long-term immunity? |
Philip A. Mudd, Kenneth E. Remy |
133 |
[GO] |
2020―Oct―21 |
Age-related susceptibility to Coronavirus infections: role of impaired and dysregulated host immunity |
Rudragouda Channappanavar, Stanley Perlman |
134 |
[GO] |
2020―Oct―16 |
SARS-CoV-2 specific antibody rearrangements in pre-pandemic immune repertoires of risk cohorts and COVID-19 patients |
Lisa Paschold, Donjete Simnica, Edith Willscher, Maria J.G.T. Vehreschild, Jochen Dutzmann, Daniel G. Sedding, et al. (+2) Christoph Schultheiß, Mascha Binder |
135 |
[GO] |
2020―Oct―15 |
What are protective antibody responses to pandemic SARS-CoV-2? |
Jeffrey P. Henderson |
136 |
[GO] |
2020―Oct―06 |
COVID-19 and myeloid cells: complex interplay correlates with lung severity |
Franco R. D'Alessio, Nicola M. Heller |
137 |
[GO] |
2020―Sep―30 |
Recent endemic coronavirus infection is associated with less severe COVID-19 |
Manish Sagar, Katherine Reifler, Michael Rossi, Nancy S. Miller, Pranay Sinha, Laura White, Joseph P. Mizgerd |
138 |
[GO] |
2020―Sep―29 |
COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike Receptor Binding Domain |
Massimiliano Secchi, Elena Bazzigaluppi, Cristina Brigatti, Ilaria Marzinotto, Cristina Tresoldi, Patrizia Rovere-Querini, et al. (+7) Andrea Poli, Antonella Castagna, Gabriella Scarlatti, Alberto Zangrillo, Fabio Ciceri, Lorenzo Piemonti, Vito Lampasona |
139 |
[GO] |
2020―Sep―25 |
Corticosteroids, COVID-19 pneumonia and acute respiratory distress syndrome |
Michael A. Matthay, Katherine D. Wick |
140 |
[GO] |
2020―Sep―25 |
Are T cells helpful for COVID-19: the relationship between response and risk |
Diane E. Griffin |
141 |
[GO] |
2020―Sep―23 |
Healthy donor T-cell responses to common cold coronaviruses and SARS-CoV-2 |
Bezawit A. Woldemeskel, Abena K. Kwaa, Caroline C. Garliss, Oliver Laeyendecker, Stuart C. Ray, Joel N. Blankson |
142 |
[GO] |
2020―Sep―15 |
Drugs of unproven benefit for COVID-19: a pharma perspective on ethical allocation of available therapies |
Arthur L. Caplan, Joanne Waldstreicher, Karla Childers, Aran Maree |
143 |
[GO] |
2020―Sep―14 |
Complement and coagulation: key triggers of COVID-19-induced multiorgan pathology |
Berhane Ghebrehiwet, Ellinor I. Peerschke |
144 |
[GO] |
2020―Sep―09 |
Caring for patients in a new pandemic: the necessity and challenges of observational research |
David L. Thomas |
145 |
[GO] |
2020―Sep―08 |
Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation |
Gunjan L. Shah, Susan DeWolf, Yeon Joo Lee, Roni Tamari, Parastoo B. Dahi, Jessica A. Lavery, et al. (+22) Josel D. Ruiz, Sean M. Devlin, Christina Cho, Jonathan U. Peled, Ioannis Politikos, Michael Scordo, N. Esther Babady, Tania Jain, Santosha Vardhana, Anthony F. Daniyan, Craig S. Sauter, Juliet N. Barker, Sergio A. Giralt, Cheryl Goss, Peter Maslak, Tobias M. Hohl, Mini Kamboj, Lakshmi Ramanathan, Marcel R.M. van den Brink, Esperanza B. Papadopoulos, Genovefa A. Papanicolaou, Miguel-Angel Perales |
146 |
[GO] |
2020―Sep―01 |
Immune pathogenesis of COVID-19-related Multisystem Inflammatory Syndrome in Children (MIS-C) |
Anne H. Rowley, Stanford T. Shulman, Moshe Arditi |
147 |
[GO] |
2020―Aug―25 |
Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals |
Fang Gong, Yaping Dai, Ting Zheng, Liang Cheng, Dan Zhao, Hao Wang, et al. (+5) Min Liu, Hao Pei, Tengchuan Jin, Di Yu, Pengcheng Zhou |
148 |
[GO] |
2020―Aug―24 |
SARS-CoV-2 specific T-cell responses and correlations with COVID-19 patient predisposition |
Arne Sattler, Stefan Angermair, Helena Stockmann, Katrin Moira Heim, Dmytro Khadzhynov, Sascha Treskatsch, et al. (+3) Fabian Halleck, Martin E. Kreis, Katja Kotsch |
149 |
[GO] |
2020―Aug―18 |
Baricitinib restrains the immune dysregulation in severe COVID-19 patients |
Vincenzo Bronte, Stefano Ugel, Elisa Tinazzi, Antonio Vella, Francesco De Sanctis, Stefania Canè, et al. (+24) Veronica Batani, Rosalinda Trovato, Alessandra Fiore, Varvara Petrova, Francesca Hofer, Roza Maria Barouni, Chiara Musiu, Simone Caligola, Laura Pinton, Lorena Torroni, Enrico Polati, Katia Donadello, Simonetta Friso, Francesca Pizzolo, Manuela Iezzi, Federica Facciotti, Pier Giuseppe Pelicci, Daniela Righetti, Paolo Bazzoni, Mariaelisa Rampudda, Andrea C. Comel, Walter Mosaner, Claudio Lunardi, Oliviero Olivieri |
150 |
[GO] |
2020―Aug―12 |
COVID-19 severity associates with pulmonary redistribution of CD1c+ DC and inflammatory transitional and nonclassical monocytes |
Ildefonso Sánchez-Cerrillo, Pedro Landete, Beatriz Aldave, Santiago Sánchez-Alonso, Ana Sánchez-Azofra, Ana Marcos-Jiménez, et al. (+18) Elena Ávalos, Ana Alcaraz-Serna, Ignacio de los Santos, Tamara Mateu-Albero, Laura Esparcia, Celia López-Sanz, Pedro Martínez-Fleta, Ligia Gabrie, Luciana del Campo Guerola, Hortensia de la Fuente, María J Calzada, Isidoro González-Álvaro, Arantzazu Alfranca, Francisco Sánchez-Madrid, Cecilia Muñoz-Calleja, Joan B. Soriano, Julio Ancochea, Enrique Martín-Gayo |
151 |
[GO] |
2020―Aug―07 |
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population |
Sabra L. Klein, Andrew Pekosz, Han-Sol Park, Rebecca L. Ursin, Janna R. Shapiro, Sarah E. Benner, et al. (+17) Kirsten Littlefield, Swetha Kumar, Harnish Mukesh Naik, Michael Betenbaugh, Ruchee Shrestha, Annie A. Wu, Robert M. Hughes, Imani Burgess, Patrizio Caturegli, Oliver Laeyendecker, Thomas C. Quinn, David J. Sullivan, Shmuel Shoham, Andrew D. Redd, Evan M. Bloch, Arturo Casadevall, Aaron A. R. Tobian |
152 |
[GO] |
2020―Aug―06 |
Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis |
Panagiotis Skendros, Alexandros Mitsios, Akrivi Chrysanthopoulou, Dimitrios C. Mastellos, Simeon Metallidis, Petros Rafailidis, et al. (+11) Maria Ntinopoulou, Eleni Sertaridou, Victoria Tsironidou, Christina Tsigalou, Maria G. Tektonidou, Theocharis Konstantinidis, Charalampos Papagoras, Ioannis Mitroulis, Georgios Germanidis, John D. Lambris, Konstantinos Ritis |
153 |
[GO] |
2020―Aug―03 |
Toward better preparedness for the next pandemic |
Lauren I. Shapiro, Grace R. Kajita, Julia H. Arnsten, Yaron Tomer |
154 |
[GO] |
2020―Jul―30 |
Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2 |
Caroline Diorio, Sarah E. Henrickson, Laura A. Vella, Kevin O. McNerney, Julie M. Chase, Chakkapong Burudpakdee, et al. (+31) Jessica H. Lee, Cristina Jasen, Fran Balamuth, David M. Barrett, Brenda Banwell, Kathrin M. Bernt, Allison M. Blatz, Kathleen Chiotos, Brian T. Fisher, Julie C. Fitzgerald, Jeffrey S. Gerber, Kandace Gollomp, Christopher Gray, Stephan A. Grupp, Rebecca M. Harris, Todd J. Kilbaugh, Audrey R. Odom John, Michele P. Lambert, Emily J. Liebling, Michele Paessler, Whitney Petrosa, Charles A. Phillips, Anne F. Reilly, Neil Romberg, Alix E. Seif, Deborah Sesok-Pizzini, Kathleen Sullivan, Julie Vardaro, Edward M Behrens, David T. Teachey, Hamid Bassiri |
155 |
[GO] |
2020―Jul―30 |
COVID-19, racism, and the pursuit of health care and research worthy of trust |
Lisa A. Cooper, Deidra C. Crews |
156 |
[GO] |
2020―Jul―23 |
Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children |
Pui Y. Lee, Megan Day-Lewis, Lauren A. Henderson, Kevin Friedman, Jeffrey Lo, Jordan E. Roberts, et al. (+23) Mindy S. Lo, Craig D. Platt, Janet Chou, Kacie J. Hoyt, Annette L. Baker, Tina Banzon, Margaret H. Chang, Ezra Cohen, Sarah de Ferranti, Audrey Dionne, Saddiq Habiballah, Olha Halyabar, Jonathan S. Hausmann, Melissa Hazen, Erin Janssen, Esra Meidan, Ryan W. Nelson, Alan A. Nguyen, Robert P. Sundel, Fatma Dedeoglu, Peter A. Nigrovic, Jane W. Newburger, Mary Beth F. Son |
157 |
[GO] |
2020―Jul―21 |
Prioritizing clinical research studies during the COVID-19 pandemic: lessons from New York City |
Roy M. Gulick, Magdalena E. Sobieszczyk, Donald W. Landry, Anthony N. Hollenberg |
158 |
[GO] |
2020―Jul―07 |
Kinetics of viral load and antibody response in relation to COVID-19 severity |
Yanqun Wang, Lu Zhang, Ling Sang, Feng Ye, Shicong Ruan, Bei Zhong, et al. (+38) Tie Song, Abeer N. Alshukairi, Rongchang Chen, Zhaoyong Zhang, Mian Gan, Airu Zhu, Yongbo Huang, Ling Luo, Chris KP Mok, Manal M. Al Gethamy, Haitao Tan, Zhengtu Li, Xiaofang Huang, Fang Li, Jing Sun, Yanjun Zhang, Liyan Wen, Yuming Li, Zhao Chen, Zhen Zhuang, Jianfen Zhuo, Chunke Chen, Lijun Kuang, Junxiang Wang, Huibin Lv, Yongliang Jiang, Min Li, Yimin Lin, Ying Deng, Lan Tang, Jieling Liang, Jicheng Huang, Stanley Perlman, Nanshan Zhong, Jingxian Zhao, J.S. Malik Peiris, Yimin Li, Jincun Zhao |
159 |
[GO] |
2020―Jul―07 |
SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy |
Arturo Casadevall, Michael J. Joyner, Liise-anne Pirofski |
160 |
[GO] |
2020―Jun―23 |
SARS-CoV-2 infection of the placenta |
Hillary Hosier, Shelli F. Farhadian, Raffaella A. Morotti, Uma Deshmukh, Alice Lu-Culligan, Katherine H. Campbell, et al. (+30) Yuki Yasumoto, Chantal B.F. Vogels, Arnau Casanovas-Massana, Pavithra Vijayakumar, Bertie Geng, Camila D. Odio, John Fournier, Anderson F. Brito, Joseph R. Fauver, Feimei Liu, Tara Alpert, Reshef Tal, Klara Szigeti-Buck, Sudhir Perincheri, Christopher P. Larsen, Aileen M. Gariepy, Gabriela Aguilar, Kristen L. Fardelmann, Malini Harigopal, Hugh S. Taylor, Christian M. Pettker, Anne L. Wyllie, Charles S. Dela Cruz, Aaron M. Ring, Nathan D. Grubaugh, Albert I. Ko, Tamas L. Horvath, Akiko Iwasaki, Uma M. Reddy, Heather S. Lipkind |
161 |
[GO] |
2020―Jun―11 |
Early safety indicators of COVID-19 convalescent plasma in 5,000 patients |
Michael J. Joyner, R. Scott Wright, DeLisa Fairweather, Jonathon W. Senefeld, Katelyn A. Bruno, Stephen A. Klassen, et al. (+30) Rickey E. Carter, Allan M. Klompas, Chad C. Wiggins, John R.A. Shepherd, Robert F. Rea, Emily R. Whelan, Andrew J. Clayburn, Matthew R. Spiegel, Patrick W. Johnson, Elizabeth R. Lesser, Sarah E. Baker, Kathryn F. Larson, Juan G. Ripoll, Kylie J. Andersen, David O. Hodge, Katie L. Kunze, Matthew R. Buras, Matthew N.P. Vogt, Vitaly Herasevich, Joshua J. Dennis, Riley J. Regimbal, Philippe R. Bauer, Janis E. Blair, Camille M. van Buskirk, Jeffrey L. Winters, James R. Stubbs, Nigel S. Paneth, Nicole C. Verdun, Peter Marks, Arturo Casadevall |
162 |
[GO] |
2020―May―28 |
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent |
Alessio Mazzoni, Lorenzo Salvati, Laura Maggi, Manuela Capone, Anna Vanni, Michele Spinicci, et al. (+23) Jessica Mencarini, Roberto Caporale, Benedetta Peruzzi, Alberto Antonelli, Michele Trotta, Lorenzo Zammarchi, Luca Ciani, Leonardo Gori, Chiara Lazzeri, Andrea Matucci, Alessandra Vultaggio, Oliviero Rossi, Fabio Almerigogna, Paola Parronchi, Paolo Fontanari, Federico Lavorini, Adriano Peris, Gian Maria Rossolini, Alessandro Bartoloni, Sergio Romagnani, Francesco Liotta, Francesco Annunziato, Lorenzo Cosmi |
163 |
[GO] |
2020―May―28 |
New York City COVID-19 resident physician exposure during exponential phase of pandemic |
Mark P. Breazzano, Junchao Shen, Aliaa H. Abdelhakim, Lora Dagi Glass, Jason Horowitz, Sharon X. Xie, et al. (+3) C. Gustavo De Moraes, Alice Chen-Plotkin, Royce W.S. Chen |
164 |
[GO] |
2020―May―27 |
COVID-19, microangiopathy, hemostatic activation, and complement |
Wen-Chao Song, Garret A. FitzGerald |
165 |
[GO] |
2020―May―11 |
Clinical trials for COVID-19 should include sex as a variable |
Evelyne Bischof, Jeannette Wolfe, Sabra L. Klein |
166 |
[GO] |
2020―Apr―30 |
Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists |
Maximilian F. Konig, Michael A. Powell, Verena Staedtke, Ren-Yuan Bai, David L. Thomas, Nicole M. Fischer, et al. (+12) Sakibul Huq, Adham M. Khalafallah, Allison Koenecke, Ruoxuan Xiong, Brett Mensh, Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Joshua T. Vogelstein, Susan Athey, Shibin Zhou, Chetan Bettegowda |
167 |
[GO] |
2020―Apr―30 |
Prototype pathogen approach for pandemic preparedness: world on fire |
Barney S. Graham, Kizzmekia S. Corbett |
168 |
[GO] |
2020―Apr―24 |
Panic prescribing has become omnipresent during the COVID-19 pandemic |
Arthur L. Caplan, Ross Upshur |
169 |
[GO] |
2020―Apr―07 |
Deployment of convalescent plasma for the prevention and treatment of COVID-19 |
Evan M. Bloch, Shmuel Shoham, Arturo Casadevall, Bruce S. Sachais, Beth Shaz, Jeffrey L. Winters, et al. (+21) Camille van Buskirk, Brenda J. Grossman, Michael Joyner, Jeffrey P. Henderson, Andrew Pekosz, Bryan Lau, Amy Wesolowski, Louis Katz, Hua Shan, Paul G. Auwaerter, David Thomas, David J. Sullivan, Nigel Paneth, Eric Gehrie, Steven Spitalnik, Eldad Hod, Lewis Pollack, Wayne T. Nicholson, Liise-anne Pirofski, Jeffrey A. Bailey, Aaron A.R. Tobian |
170 |
[GO] |
2020―Apr―06 |
Kidney diseases in the time of COVID-19: major challenges to patient care |
Hamid Rabb |
171 |
[GO] |
2020―Apr―03 |
The COVID-19 pandemic and research shutdown: staying safe and productive |
M. Bishr Omary, Jeetendra R. Eswaraka, S. David Kimball, Prabhas V. Moghe, Reynold A. Panettieri, Jr., Kathleen W. Scotto |
172 |
[GO] |
2020―Mar―30 |
COVID-19 threatens health systems in sub-Saharan Africa: the eye of the crocodile |
Elijah Paintsil |
173 |
[GO] |
2020―Mar―27 |
Clinical and immunologic features in severe and moderate Coronavirus Disease 2019 |
Guang Chen, Di Wu, Wei Guo, Yong Cao, Da Huang, Hongwu Wang, et al. (+14) Tao Wang, Xiaoyun Zhang, Huilong Chen, Haijing Yu, Xiaoping Zhang, Minxia Zhang, Shiji Wu, Jianxin Song, Tao Chen, Meifang Han, Shusheng Li, Xiaoping Luo, Jianping Zhao, Qin Ning |
174 |
[GO] |
2020―Mar―27 |
SARS-CoV-2: A Storm is Raging |
Savannah F. Pedersen, Ya-Chi Ho |
175 |
[GO] |
2020―Mar―22 |
Changing the editorial process at JCI and JCI Insight in response to the COVID-19 pandemic |
Rexford S. Ahima, Sarah Jackson, Arturo Casadevall, Gregg L. Semenza, Gordon Tomaselli, Kathleen L. Collins, et al. (+3) Andrew P. Lieberman, Donna M. Martin, Pavan Reddy |
176 |
[GO] |
2020―Mar―13 |
The convalescent sera option for containing COVID-19 |
Arturo Casadevall, Liise-anne Pirofski |
|